porcin
deltacoronaviru
pdcov
emerg
global
swine
viru
propens
interspeci
transmiss
identifi
hong
kong
given
neither
specif
antivir
drug
vaccin
avail
newli
emerg
porcin
deltacoronaviru
search
effect
antivir
drug
high
prioriti
studi
lithium
chlorid
licl
diammonium
glycyrrhizin
dg
hostact
antivir
haa
test
pdcov
found
licl
dg
inhibit
pdcov
replic
cell
dosedepend
manner
antivir
effect
licl
dg
occur
earli
stage
pdcov
replic
dg
also
inhibit
viru
attach
cell
moreov
drug
inhibit
pdcovinduc
apoptosi
cell
studi
suggest
licl
dg
new
drug
treatment
pdcov
infect
pdcov
strain
lab
use
studi
number
infecti
pdcov
particl
determin
basi
tissu
cultur
infecti
dose
tcid
cell
briefli
cell
seed
plate
grown
confluenc
h
cell
infect
use
serial
dilut
viru
sampl
incub
c
h
cell
wash
three
time
pb
incub
h
titer
report
tcid
calcul
method
reed
muench
cytotox
licl
dg
assess
vitro
use
cell
count
houston
tx
usa
accord
manufactur
instruct
cell
seed
plate
grown
confluenc
h
wash
three
time
pb
cell
treat
increas
concentr
licl
rang
mm
dg
rang
mocktreat
cell
serv
control
h
cell
wash
pb
incub
dmem
solut
c
h
absorb
measur
micropl
reader
tecan
pro
ch
nm
cytotox
express
accord
follow
formula
cytotox
ab
sampl
ab
blank
ab
neg
control
ab
blank
investig
antivir
efficaci
licl
dg
pdcov
replic
cell
infect
pdcov
moi
c
h
unbound
virus
remov
wash
cold
pb
cell
incub
licl
mm
dg
c
h
control
anoth
set
cell
infect
dose
pdcov
without
drug
treatment
subsequ
antivir
efficaci
evalu
analysi
viral
rna
vrna
level
viral
load
cell
seed
plate
grown
confluenc
h
nontox
concentr
licl
mm
dg
mix
viru
moi
mixtur
ad
cell
follow
incub
h
c
control
cell
infect
dose
pdcov
without
drug
treatment
wash
cold
pb
level
vrna
cell
determin
realtim
qpcr
pdcov
moi
incub
h
room
temperatur
c
absenc
presenc
licl
mm
dg
final
volum
incub
infecti
titer
determin
tcid
cell
cell
infect
pdcov
moi
c
h
unbound
virus
remov
wash
cold
pb
cell
incub
licl
mm
dg
c
h
control
anoth
set
cell
infect
dose
pdcov
without
drug
treatment
remov
unbound
virus
wash
cold
pb
ph
level
vrna
cell
determin
realtim
qpcr
total
cellular
rna
extract
use
rnapur
tissu
cell
kit
cwbio
nanj
china
primer
pdcov
gene
pdcovf
pdcovr
quantiti
vrna
determin
use
roch
germani
hiscript
ii
one
step
qrtpcr
sybr
green
kit
vazym
nanj
china
accord
instruct
manufactur
rel
level
rna
express
determin
method
mrna
level
use
load
control
mean
rna
level
mocktreat
group
set
infect
cell
fix
cold
polysorb
min
room
temperatur
permeabil
triton
pb
min
wash
five
time
pb
cthe
ell
incub
rabbit
antin
antibodi
c
h
cell
incub
fitcconjug
goat
antirabbit
igg
kpl
colton
ca
usa
c
min
wash
five
time
pb
cell
incub
dapi
dilut
pb
room
temperatur
min
fluoresc
observ
nikon
eclips
fluoresc
microscop
nikon
tokyo
japan
apoptosi
investig
use
annexinv
alexa
kit
flow
cytometri
cell
detach
use
accutas
cell
detach
solut
fmsat
min
centrifug
rpm
min
cell
wash
twice
pb
resuspend
bind
buffer
concentr
cellsml
annexinv
pi
ad
cell
follow
incub
room
temperatur
min
dark
flow
cytometri
carri
becton
dickinson
accuri
facscalibur
cytomet
bd
accuri
plu
bd
medic
devic
shanghai
co
ltd
shanghai
china
concentr
drug
caus
cellular
cytotox
refer
cc
experi
perform
triplic
data
repres
mean
standard
deviat
sd
statist
differ
determin
use
pair
ttest
oneway
anova
use
prism
softwar
graphpad
softwar
pvalu
select
indic
signific
licl
dg
cytotox
cell
cellular
cytotox
effect
licl
dg
cell
determin
use
kit
structur
dg
shown
figur
maximum
licl
dg
concentr
result
cell
viabil
higher
mm
respect
figur
c
differ
cell
morpholog
compar
mocktreat
cell
observ
data
shown
concentr
mm
licl
dg
therefor
mm
licl
dg
use
subsequ
antivir
assay
licl
dg
inhibit
pdcov
replic
next
investig
effect
licl
dg
replic
pdcov
cell
cell
infect
pdcov
moi
h
treat
mm
licl
dg
h
rel
mrna
express
detect
realtim
qpcr
treatment
mm
licl
dg
inhibit
viral
mrna
level
significantli
figur
infecti
viru
load
cell
cultur
supernat
determin
tcid
found
mm
licl
dg
significantli
inhibit
viral
replic
compar
mocktreat
cell
figur
ifa
fluoresc
intens
declin
treatment
mm
licl
dg
dosedepend
manner
figur
fluoresc
intens
quantifi
show
number
infect
cell
decreas
drug
dosedepend
manner
figur
result
indic
licl
dg
inhibit
pdcov
replic
dosedepend
manner
licl
dg
cytotox
cell
cellular
cytotox
effect
licl
dg
cell
determin
use
kit
structur
dg
shown
figur
maximum
licl
dg
concentr
result
cell
viabil
higher
mm
respect
figur
c
differ
cell
morpholog
compar
mocktreat
cell
observ
data
shown
concentr
mm
licl
dg
therefor
mm
licl
dg
use
subsequ
antivir
assay
licl
dg
inhibit
pdcov
replic
next
investig
effect
licl
dg
replic
pdcov
cell
cell
infect
pdcov
moi
h
treat
mm
licl
dg
h
rel
mrna
express
detect
realtim
qpcr
treatment
mm
licl
dg
inhibit
viral
mrna
level
significantli
figur
infecti
viru
load
cell
cultur
supernat
determin
found
mm
licl
dg
significantli
inhibit
viral
replic
compar
mocktreat
cell
figur
ifa
fluoresc
intens
declin
treatment
mm
licl
dg
dosedepend
manner
figur
fluoresc
intens
quantifi
show
number
infect
cell
decreas
drug
dosedepend
manner
figur
result
indic
licl
dg
inhibit
pdcov
replic
dosedepend
manner
dg
licl
inhibit
viru
attach
cell
explor
step
viral
life
cycl
drug
work
viral
attach
entri
assay
perform
cell
signific
differ
mocktreat
cell
cell
treat
mm
licl
viral
attach
entri
base
mean
rel
viral
mrna
level
figur
entri
experi
signific
differ
mocktreat
cell
cell
treat
dg
mean
rel
viral
mrna
level
viral
attach
assay
dg
treatment
led
signific
reduct
viral
mrna
level
compar
mocktreat
cell
figur
licl
dg
viricid
effect
pdcov
virion
understand
whether
licl
dg
direct
viricid
effect
virion
incub
pdcov
moi
mm
licl
dg
h
room
temperatur
c
infect
cell
infecti
titer
determin
tcid
hour
postinfect
hpi
found
none
drug
directli
inhibit
pdcov
infect
figur
b
antivir
effect
licl
dg
occur
earli
stage
pdcov
replic
illustr
effect
licl
dg
pdcov
infect
perform
time
addit
experi
figur
therefor
licl
dg
ad
infect
cell
differ
time
hpi
experi
drug
viru
ad
togeth
cell
h
cell
wash
incub
continu
presenc
drug
experi
cell
infect
pdcov
h
cell
wash
drug
ad
hpi
experi
cell
infect
pdcov
multipl
infect
moi
mm
licl
dg
ad
viral
content
significantli
reduc
cell
treat
licl
h
signific
reduct
detect
h
figur
dg
latest
effect
time
point
drug
treatment
hpi
figur
therefor
conclud
antivir
effect
licl
dg
occur
earli
stage
pdcov
replic
green
fluoresc
repres
pdcov
replic
blue
fluoresc
repres
nuclear
distribut
fluoresc
intens
c
quantifi
softwar
imagej
quantif
pdcovinfect
cell
ifa
imag
present
percentag
take
mm
licl
valu
repres
mean
sd
three
independ
experi
ns
signific
differ
p
p
p
scale
bar
dg
licl
inhibit
viru
attach
cell
explor
step
viral
life
cycl
drug
work
viral
attach
entri
assay
perform
cell
signific
differ
mocktreat
cell
cell
treat
mm
licl
viral
attach
entri
base
mean
rel
viral
mrna
level
figur
entri
experi
signific
differ
mocktreat
cell
cell
treat
dg
mean
rel
viral
mrna
level
viral
attach
assay
dg
treatment
led
signific
reduct
viral
mrna
level
compar
mocktreat
cell
figur
dg
licl
inhibit
viru
attach
cell
explor
step
viral
life
cycl
drug
work
viral
attach
entri
assay
perform
cell
signific
differ
mocktreat
cell
cell
treat
mm
licl
viral
attach
entri
base
mean
rel
viral
mrna
level
figur
entri
experi
signific
differ
mocktreat
cell
cell
treat
dg
mean
rel
viral
mrna
level
viral
attach
assay
dg
treatment
led
signific
reduct
viral
mrna
level
compar
mocktreat
cell
figur
licl
dg
viricid
effect
pdcov
virion
understand
whether
licl
dg
direct
viricid
effect
virion
incub
pdcov
moi
mm
licl
dg
h
room
temperatur
infect
cell
infecti
titer
determin
hour
postinfect
hpi
found
none
drug
directli
inhibit
pdcov
infect
figur
b
figur
therefor
licl
dg
ad
infect
cell
differ
time
hpi
experi
drug
viru
ad
togeth
cell
h
cell
wash
incub
continu
presenc
drug
experi
cell
infect
pdcov
h
cell
wash
drug
ad
hpi
experi
cell
infect
pdcov
multipl
infect
moi
mm
licl
dg
ad
viral
content
significantli
reduc
cell
treat
licl
h
signific
reduct
detect
h
figur
dg
latest
effect
time
point
drug
treatment
hpi
figur
therefor
conclud
antivir
effect
licl
dg
occur
earli
stage
pdcov
replic
licl
dg
inhibit
apoptosi
caus
pdcov
infect
annexinv
alexa
kit
use
detect
cell
apoptosi
found
pdcov
could
caus
apoptosi
within
hpi
percentag
apoptot
cell
infect
mocktreat
licltreat
virus
dgtreat
virus
respect
figur
addit
drug
present
apoptosisinhibit
trend
therefor
conclud
licl
dg
inhibit
cell
apoptosi
caus
pdcov
infect
figur
viricid
effect
licl
dg
pdcov
pdcov
virion
incub
mm
licl
c
room
temperatur
viral
titer
log
tcid
ml
calcul
method
reed
muench
b
experi
use
dg
valu
repres
mean
sd
three
independ
experi
ns
signific
differ
p
p
p
figur
viricid
effect
licl
dg
pdcov
pdcov
virion
incub
mm
licl
room
temperatur
viral
titer
calcul
method
reed
muench
b
experi
use
dg
valu
repres
mean
sd
three
independ
experi
ns
signific
differ
p
p
p
antivir
effect
licl
dg
occur
earli
stage
pdcov
replic
illustr
effect
licl
dg
pdcov
infect
perform
time
addit
experi
figur
therefor
licl
dg
ad
infect
cell
differ
time
hpi
experi
drug
viru
ad
togeth
cell
h
cell
wash
incub
continu
presenc
drug
experi
cell
infect
pdcov
h
cell
wash
drug
ad
hpi
experi
cell
infect
pdcov
multipl
infect
moi
mm
licl
dg
ad
viral
content
significantli
reduc
cell
treat
licl
h
signific
reduct
detect
h
figur
dg
latest
effect
time
point
drug
treatment
hpi
figur
therefor
conclud
antivir
effect
licl
dg
occur
earli
stage
pdcov
replic
licl
dg
inhibit
apoptosi
caus
pdcov
infect
annexinv
alexa
kit
use
detect
cell
apoptosi
found
pdcov
could
caus
apoptosi
within
hpi
percentag
apoptot
cell
infect
mocktreat
licltreat
virus
dgtreat
virus
respect
figur
addit
drug
present
apoptosisinhibit
trend
therefor
conclud
licl
dg
inhibit
cell
apoptosi
caus
pdcov
infect
licl
dg
inhibit
apoptosi
caus
pdcov
infect
annexinv
alexa
kit
use
detect
cell
apoptosi
found
pdcov
could
caus
apoptosi
within
hpi
percentag
apoptot
cell
infect
mocktreat
licltreat
virus
dgtreat
virus
respect
figur
addit
drug
present
apoptosisinhibit
trend
therefor
conclud
licl
dg
inhibit
cell
apoptosi
caus
pdcov
infect
pdcov
infect
caus
vomit
wateri
diarrhea
piglet
serious
damag
growth
pig
industri
record
clinic
effect
agent
treatment
pdcov
infect
compound
shown
antivir
activ
therefor
urgent
need
develop
good
approach
prevent
pdcov
infect
neither
specif
antivir
drug
vaccin
avail
newli
emerg
virus
possibl
develop
smallmolecul
drug
vaccin
act
pdcov
short
period
time
novel
use
tradit
drug
long
consid
import
mean
find
new
therapi
target
new
infecti
diseas
report
licl
dg
often
deem
broadspectrum
antivir
reagent
antivir
properti
coronavirus
sarscov
ibv
pedv
howev
remain
unknown
whether
licl
dg
inhibitori
effect
pdcov
infect
studi
use
realtim
qpcr
tcid
ifa
analyz
pdcov
infect
realtim
qpcr
use
analyz
level
pdcov
mrna
express
pdcov
replic
infecti
titer
determin
tcid
fluoresc
signal
detect
ifa
repres
level
pdcov
protein
express
found
licl
dg
inhibit
replic
pdcov
cell
dosedepend
manner
perform
timeofaddit
experi
aim
identifi
stage
viral
replic
cycl
target
drug
found
drug
reduc
viral
rna
cell
lysat
earli
stage
pdcov
replic
viral
replic
cycl
includ
attach
entri
transcript
replic
gene
express
assembl
matur
releas
found
dg
inhibit
attach
viru
cell
surfac
consist
result
recent
report
show
glycyrrhizin
achiev
dosedepend
inhibit
replic
cell
could
interfer
viruscel
bind
howev
specif
mechan
need
investig
futur
experi
determin
dg
use
treatment
also
prevent
pdcov
infect
dg
good
water
solubl
use
aerosol
disinfect
piggeri
prevent
outbreak
porcin
epidem
diarrhea
accord
antivir
effect
antivir
activ
licl
better
dg
toxic
dg
less
licl
investig
effect
licl
combin
dg
replic
pdcov
cell
signific
differ
licltreat
cell
cell
treat
licl
dg
mean
rel
viral
mrna
level
indic
synergi
inhibit
viral
replic
drug
use
combin
data
shown
also
found
licl
dg
could
inhibit
cell
apoptosi
caus
pdcov
infect
similarli
result
previou
report
apoptosi
consid
host
innat
defens
mechan
elimin
virusinfect
cell
howev
virus
use
trigger
apoptosi
facilit
releas
viral
progeni
dissemin
fundament
viral
pathogenesi
diseas
develop
promot
cell
death
tissu
injuri
previou
studi
show
pdcov
induc
caspasedepend
apoptosi
activ
cytochrom
cmediat
intrins
mitochondri
pathway
whether
licl
dg
inhibit
pdcovinduc
apoptosi
suppress
cytochrom
cmediat
intrins
mitochondri
pathway
need
studi
conclus
result
indic
licl
dg
potenti
effect
antipdcov
drug
outbreak
porcin
epidem
diarrhea
licl
dg
could
ad
drink
water
appropri
dose
given
intramuscular
drug
treatment
earli
onset
epidem
studi
requir
explor
antivir
effect
cov
mechan
action
control
pdcov
infect
vivo
